VITAMIN D3 KRKA 7000 UI România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

vitamin d3 krka 7000 ui

krka, d.d., novo mesto - slovenia - colecalciferolum - compr. - 7000ui - vitamina a si d (incl. combinatii) vitamina d si analogi

Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) Uniunea Europeană - română - EMA (European Medicines Agency)

lenalidomide krka (previously lenalidomide krka d.d. novo mesto)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - imunosupresoare - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 și 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) este indicat pentru tratamentul pacienților adulți cu mielom multiplu netratați anterior, care nu sunt eligibili pentru transplant. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 și 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

ROSUVASTATINA KRKA 5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rosuvastatina krka 5 mg

krka d.d. novo mesto - slovenia - rosuvastatinum - compr. film. - 5mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei

ROSUVASTATINA KRKA 10 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rosuvastatina krka 10 mg

krka d.d. novo mesto - slovenia - rosuvastatinum - compr. film. - 10mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei

ROSUVASTATINA KRKA 20 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rosuvastatina krka 20 mg

krka d.d. novo mesto - slovenia - rosuvastatinum - compr. film. - 20mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei

ROSUVASTATINA KRKA 40 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

rosuvastatina krka 40 mg

krka d.d. novo mesto - slovenia - rosuvastatinum - compr. film. - 40mg - hipocolesterolemiante si hipotrigliceridemiante inhibitori ai hmg coa reductazei

PANTOPRAZOL KRKA 20 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pantoprazol krka 20 mg

krka, d.d., novo mesto - slovenia - letrozolum - compr. gastrorez. - 20mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei de protoni

PANTOPRAZOL KRKA 40 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pantoprazol krka 40 mg

krka, d.d., novo mesto - slovenia - letrozolum - compr. gastrorez. - 40mg - med. pt. trat. ulcerului gastro-duodenal si bolii-reflux g.e inhibitori ai pompei de protoni

LINEZOLID KRKA 600 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

linezolid krka 600 mg

krka, d.d., novo mesto - slovenia - linezolidum - compr. film. - 600mg - alte antibacteriene alte antibacteriene

BORTEZOMIB KRKA 1 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

bortezomib krka 1 mg

krka, d.d., novo mesto - slovenia - bortezomibum - pulb. pt. sol. inj. - 1mg - alte antineoplazice inhibitori de proteazom